Tubulis generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Their goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. They will adva... Read more
Isotopen Technologien München
1 follower
BioNTech
42 followers
Miltenyi Biotec
10 followers
Vera Therapeutics
6 followers
Vaxcyte
5 followers
Mineralys Therapeutics
3 followers
Capricor Therapeutics
2 followers
Immunome
2 followers
SCYNEXIS
2 followers
KWS Group
10 followers
Imbria Pharmaceuticals
2 followers
Queen Mary University
7 followers